Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2005
12/22/2005WO2005121143A1 Flavopereirine derivatives for cancer therapy
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121134A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents
12/22/2005WO2005121120A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors
12/22/2005WO2005121105A1 Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medicinal use thereof
12/22/2005WO2005120577A2 Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity
12/22/2005WO2005120560A1 Bacterial compositions for the treatment of cancer
12/22/2005WO2005120525A1 Pharmaceutical active substance extracted from lycosa tarantula
12/22/2005WO2005120495A1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody
12/22/2005WO2005120480A1 Antitumor effect fortifier, antitumor agent and method of therapy for cancer
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282876 Inhibitors of IMPDH enzyme
12/22/2005US20050282873 Epothilone derivative for the treatment of hepatoma and other cancer diseases
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282871 3-(3,5-Disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282856 3-Cyano-quinoline derivatives
12/22/2005US20050282838 Compounds, compositions, and methods
12/22/2005US20050282810 Oxindole derivatives
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282786 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
12/22/2005US20050282783 Obtained by reacting sodium zoledronate with calcium orthophosphates in water, bone remodeling equilibrium; the local treatment of a bone problem on the main at-risk sites identified (neck of the femur )
12/22/2005US20050282766 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
12/22/2005US20050282762 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
12/22/2005US20050282742 Such as bortezomib, by freeze drying
12/22/2005US20050282740 Methods and compositions for regulating protein-protein interactions
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides
12/22/2005US20050282157 Using oligonucleotide and peptide nucleic acid oligomers for use as diagnostic tool in monitoring cytosine methylation; detecting cell proliferative, inflammatory, connective, bone, nervous system and cardiovascular disorders
12/22/2005US20050282147 Methods for assaying gene imprinting and methylated CpG islands
12/22/2005US20050281904 Kefir extract as an anti-cancer agent
12/22/2005US20050281892 Highly efficacious and highly safe composition of a Stilbene derivative and a platinum coordination compound cis-diaminedichloroplatinum (II)
12/22/2005US20050281834 Altered peptide ligands
12/22/2005US20050281831 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors
12/22/2005US20050281825 peptide transport proteins (PepTs); has antibody-dependent cell-mediated cytotoxic (ADCC) activity; cancer
12/22/2005US20050281824 Methods of using IMXP-888 and IMXP-888 antagonists
12/22/2005US20050281812 Antibodies to insulin-like growth factor I receptor
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050281787 Tumor-specific vector for gene therapy
12/22/2005US20050281785 Method of reducing side effects of cancer therapy using p53 recombinant adenovirus
12/22/2005CA2727841A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido [2, 3-d] pyrimidine derivatives and related compounds
12/22/2005CA2611377A1 Bacterial compositions for the treatment of cancer
12/22/2005CA2573430A1 Anti-perp antibody
12/22/2005CA2570458A1 Antibodies for selective apoptosis of cells
12/22/2005CA2570073A1 Protein kinase inhibitors
12/22/2005CA2569788A1 Tumor specific antibody
12/22/2005CA2569675A1 Cationic bacteriochlorophyll derivatives and uses thereof
12/22/2005CA2569623A1 Novel compounds and use of tetrahydropyridothiophenes
12/22/2005CA2568995E Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
12/22/2005CA2568306A1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody
12/22/2005CA2568301A1 3-phenyltetrahydrocinnolin-5-ol derivatives and medicinal use thereof of
12/22/2005CA2566525A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents
12/22/2005CA2566515A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors
12/22/2005CA2566512A1 Hydroxamates, their manufacture and use as pharmaceutical agents
12/22/2005CA2565124A1 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/22/2005CA2564197A1 Activatable particles, preparations and uses
12/21/2005EP1607483A1 A recombinant constructed by a virus vector and a human tumor suppressor gene and its use
12/21/2005EP1607402A1 Method for the diagnosis of tumour
12/21/2005EP1607399A2 BIS-(N,N'-BIS-(2-Haloethyl)Amino) Phosphoramidates as antitumor agents
12/21/2005EP1607101A1 Degradation inhibitor for hepatitis b virus x interacting protein
12/21/2005EP1607092A1 Release control compositions
12/21/2005EP1607087A1 Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
12/21/2005EP1606625A1 Use of substances inhibiting the association of smad protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp
12/21/2005EP1606406A2 SHORT INTERFERING RNA (siRNA) ANALOGUES
12/21/2005EP1606405A2 Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs
12/21/2005EP1606314A2 Fc REGION VARIANTS
12/21/2005EP1606307A1 ESTRIENO(3,2-b)/(3,4-c)PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS
12/21/2005EP1606305A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1606302A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
12/21/2005EP1606284A1 Compositions useful as protein kinase inhibitors
12/21/2005EP1606283A2 P38 inhibitors and methods of use thereof
12/21/2005EP1606268A1 Heterocyclic kinase inhibitors
12/21/2005EP1605970A2 Anti-cancer virus desensitization method
12/21/2005EP1605964A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE
12/21/2005EP1605961A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1605953A2 Heterobifunctional polymeric bioconjugates
12/21/2005EP1605952A1 Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs
12/21/2005EP1605946A2 Thiazoles useful as inhibitors of protein kinases
12/21/2005EP1605943A2 1-amino 1h-imidazoquinolines
12/21/2005EP1605941A1 SUBSTITUTED PIPERIDINES AS NOVEL MDM2-p53 INHIBITORS
12/21/2005EP1605939A1 Pharmaceutical use of 1-azabicyclo[ 2.2.2] octanes and a method of testing compounds for the ability of activating inactive wt p53
12/21/2005EP1605937A1 Treatment of proliferative diseases with epothilone derivatives and radiation
12/21/2005EP1605896A2 7-amino- isoindolyl compounds amd their pharmaceutical uses
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1490391B1 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring substituted with a long chain at the 11beta position
12/21/2005EP1465898B1 Biocidal compounds and their preparation
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1313738B1 Process for the preparation and purification of thiol-containing maytansinoids
12/21/2005EP1286674A4 Methods and compositions for potentiating cancer chemotherapeutic agents
12/21/2005EP1278759B1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
1 ... 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 ... 2211